{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:41:16Z","timestamp":1774971676491,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB\/ECSA\/2020\/002"],"award-info":[{"award-number":["HRB\/ECSA\/2020\/002"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001636","name":"University College Cork","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001636","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40266-026-01293-x","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:54:59Z","timestamp":1774112099000},"page":"373-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating Potential Prescribing Cascades Resulting in Prochlorperazine Prescription: An Exploratory Analysis of Antihypertensives and NSAIDs"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5823-9614","authenticated-orcid":false,"given":"Steven","family":"Gilmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9315-2956","authenticated-orcid":false,"given":"Emma","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4149-1574","authenticated-orcid":false,"given":"Ann Sin\u00e9ad","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"1293_CR1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","volume":"315","author":"PA Rochon","year":"1997","unstructured":"Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315:1096. https:\/\/doi.org\/10.1136\/bmj.315.7115.1096.","journal-title":"BMJ"},{"key":"1293_CR2","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/s0140-6736(17)31188-1","volume":"389","author":"PA Rochon","year":"2017","unstructured":"Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017;389:1778\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(17)31188-1.","journal-title":"Lancet"},{"key":"1293_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamainternmed.2019.7087","volume":"180","author":"RD Savage","year":"2020","unstructured":"Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, et al. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med. 2020;180:643\u201351. https:\/\/doi.org\/10.1001\/jamainternmed.2019.7087.","journal-title":"JAMA Intern Med"},{"key":"1293_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252161","volume":"16","author":"WN Insani","year":"2021","unstructured":"Insani WN, Whittlesea C, Alwafi H, Man KKC, Chapman S, Wei L. Prevalence of adverse drug reactions in the primary care setting: a systematic review and meta-analysis. PLoS ONE. 2021;16:e0252161. https:\/\/doi.org\/10.1371\/journal.pone.0252161.","journal-title":"PLoS ONE"},{"key":"1293_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","volume":"7","author":"AH Lavan","year":"2016","unstructured":"Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7:11\u201322. https:\/\/doi.org\/10.1177\/2042098615615472.","journal-title":"Ther Adv Drug Saf"},{"key":"1293_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1008","volume":"10","author":"AS Doherty","year":"2022","unstructured":"Doherty AS, Shahid F, Moriarty F, Boland F, Clyne B, Dreischulte T, et al. Prescribing cascades in community-dwelling adults: a systematic review. Pharmacol Res Perspect. 2022;10:e01008. https:\/\/doi.org\/10.1002\/prp2.1008.","journal-title":"Pharmacol Res Perspect"},{"key":"1293_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40266-023-01072-y","volume":"40","author":"O Adrien","year":"2023","unstructured":"Adrien O, Mohammad AK, Hugtenburg JG, McCarthy LM, Priester-Vink S, Visscher R, et al. Prescribing cascades with recommendations to prevent or reverse them: a systematic review. Drugs Aging. 2023;40:1085\u2013100. https:\/\/doi.org\/10.1007\/s40266-023-01072-y.","journal-title":"Drugs Aging"},{"key":"1293_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-022-00964-9","volume":"39","author":"LM McCarthy","year":"2022","unstructured":"McCarthy LM, Savage R, Dalton K, Mason R, Li J, Lawson A, et al. ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people. Drugs Aging. 2022;39:829\u201340. https:\/\/doi.org\/10.1007\/s40266-022-00964-9.","journal-title":"Drugs Aging"},{"key":"1293_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-025-01215-x","author":"PA Rochon","year":"2025","unstructured":"Rochon PA, O\u2019Mahony D, Cherubini A, Onder G, Petrovic M, Dalton K, et al. International expert panel\u2019s potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med. 2025. https:\/\/doi.org\/10.1007\/s41999-025-01215-x.","journal-title":"Eur Geriatr Med"},{"key":"1293_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac138","volume":"51","author":"D O\u2019Mahony","year":"2022","unstructured":"O\u2019Mahony D, Rochon PA. Prescribing cascades: we see only what we look for, we look for only what we know. Age Ageing. 2022;51:afac138. https:\/\/doi.org\/10.1093\/ageing\/afac138.","journal-title":"Age Ageing"},{"key":"1293_CR11","unstructured":"Pharmaceutical Press (Royal Pharmaceutical Society). Martindale: the complete drug reference\u2014ADR Tracker 2018. Medicines Complete. https:\/\/www-medicinescomplete-com.ucc.idm.oclc.org\/#\/adr. Accessed 19 Aug 2025."},{"key":"1293_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.15386\/mpr-1533","volume":"93","author":"D Shabani","year":"2020","unstructured":"Shabani D, Murtezani A, Tahirbegolli B, Juniku\u2013Shkololli A, Ibraimi Z. Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users. Med Pharm Rep. 2020;93:246\u201352. https:\/\/doi.org\/10.15386\/mpr-1533.","journal-title":"Med Pharm Rep"},{"key":"1293_CR13","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.4103\/0976-500X.120969","volume":"4","author":"S Chimirri","year":"2013","unstructured":"Chimirri S, Aiello R, Mazzitello C, Mumoli L, Palleria C, Altomonte M, et al. Vertigo\/dizziness as a drugs\u2019 adverse reaction. J Pharmacol Pharmacother. 2013;4:S104\u20139. https:\/\/doi.org\/10.4103\/0976-500X.120969.","journal-title":"J Pharmacol Pharmacother"},{"key":"1293_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003821","volume":"18","author":"C Bhanu","year":"2021","unstructured":"Bhanu C, Nimmons D, Petersen I, Orlu M, Davis D, Hussain H, et al. Drug-induced orthostatic hypotension: a systematic review and meta-analysis of randomised controlled trials. PLoS Med. 2021;18:e1003821. https:\/\/doi.org\/10.1371\/journal.pmed.1003821.","journal-title":"PLoS Med"},{"key":"1293_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n189","author":"A Albasri","year":"2021","unstructured":"Albasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox SE, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n189.","journal-title":"BMJ"},{"key":"1293_CR16","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1002\/lary.24806","volume":"124","author":"HW Lin","year":"2014","unstructured":"Lin HW, Bhattacharyya N. Impact of dizziness and obesity on the prevalence of falls and fall-related injuries. Laryngoscope. 2014;124:2797\u2013801. https:\/\/doi.org\/10.1002\/lary.24806.","journal-title":"Laryngoscope"},{"key":"1293_CR17","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1001\/archinte.168.19.2118","volume":"168","author":"HK Neuhauser","year":"2008","unstructured":"Neuhauser HK, Radtke A, von Brevern M, Lezius F, Feldmann M, Lempert T. Burden of dizziness and vertigo in the community. Arch Intern Med. 2008;168:2118\u201324. https:\/\/doi.org\/10.1001\/archinte.168.19.2118.","journal-title":"Arch Intern Med"},{"key":"1293_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-11-2","volume":"11","author":"OR Maarsingh","year":"2010","unstructured":"Maarsingh OR, Dros J, Schellevis FG, van Weert HC, Bindels PJ, van der Horst HE. Dizziness reported by elderly patients in family practice: prevalence, incidence, and clinical characteristics. BMC Fam Pract. 2010;11:2. https:\/\/doi.org\/10.1186\/1471-2296-11-2.","journal-title":"BMC Fam Pract"},{"key":"1293_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12603-009-0073-2","volume":"13","author":"KG Gassmann","year":"2009","unstructured":"Gassmann KG, Group IZGS. Dizziness in an older community dwelling population: a multifactorial syndrome. J Nutr Health Aging. 2009;13:278\u201382. https:\/\/doi.org\/10.1007\/s12603-009-0073-2.","journal-title":"J Nutr Health Aging"},{"key":"1293_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.archger.2012.08.013","volume":"56","author":"UO M\u00f6ller","year":"2013","unstructured":"M\u00f6ller UO, Midl\u00f6v P, Kristensson J, Ekdahl C, Berglund J, Jakobsson U. Prevalence and predictors of falls and dizziness in people younger and older than 80 years of age\u2014a longitudinal cohort study. Arch Gerontol Geriatr. 2013;56:160\u20138. https:\/\/doi.org\/10.1016\/j.archger.2012.08.013.","journal-title":"Arch Gerontol Geriatr"},{"key":"1293_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1159\/000235812","volume":"55","author":"A Ekwall","year":"2009","unstructured":"Ekwall A, Lindberg \u00c5, Magnusson M. Dizzy\u2014why not take a walk? Low level physical activity improves quality of life among elderly with dizziness. Gerontology. 2009;55:652\u20139. https:\/\/doi.org\/10.1159\/000235812.","journal-title":"Gerontology"},{"key":"1293_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0163-8343(01)00184-0","volume":"24","author":"TT Haug","year":"2002","unstructured":"Haug TT, Mykletun A, Dahl AA. The prevalence of nausea in the community: psychological, social and somatic factors. Gen Hosp Psychiatry. 2002;24:81\u20136. https:\/\/doi.org\/10.1016\/S0163-8343(01)00184-0.","journal-title":"Gen Hosp Psychiatry"},{"key":"1293_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","volume":"143","author":"AF Peery","year":"2012","unstructured":"Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179-1187.e3. https:\/\/doi.org\/10.1053\/j.gastro.2012.08.002.","journal-title":"Gastroenterology"},{"key":"1293_CR24","first-page":"154","volume":"95","author":"HL Muncie","year":"2017","unstructured":"Muncie HL, Sirmans SM, James E. Dizziness: approach to evaluation and management. Am Fam Physician. 2017;95:154\u201362.","journal-title":"Am Fam Physician"},{"key":"1293_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/1756283X15618131","volume":"9","author":"P Singh","year":"2016","unstructured":"Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Ther Adv Gastroenterol. 2016;9:98\u2013112. https:\/\/doi.org\/10.1177\/1756283X15618131.","journal-title":"Ther Adv Gastroenterol"},{"key":"1293_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40266-021-00855-5","volume":"38","author":"G Bahat","year":"2021","unstructured":"Bahat G, Ilhan B, Erdogan T, Oren MM, Karan MA, Burkhardt H, et al. International validation of the Turkish inappropriate medication use in the elderly (TIME) criteria set: a Delphi panel study. Drugs Aging. 2021;38:513\u201321. https:\/\/doi.org\/10.1007\/s40266-021-00855-5.","journal-title":"Drugs Aging"},{"key":"1293_CR27","doi-asserted-by":"publisher","DOI":"10.1370\/afm.240383","author":"AS Doherty","year":"2025","unstructured":"Doherty AS, Lund LC, Moriarty F, Boland F, Clyne B, Fahey T, et al. Prescribing cascades among older community-dwelling adults: application of prescription sequence symmetry analysis to a national database in Ireland. Ann Fam Med. 2025. https:\/\/doi.org\/10.1370\/afm.240383.","journal-title":"Ann Fam Med"},{"key":"1293_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/pds.2009","volume":"19","author":"GE Caughey","year":"2010","unstructured":"Caughey GE, Roughead EE, Pratt N, Shakib S, Vitry AI, Gilbert AL. Increased risk of hip fracture in the elderly associated with prochlorperazine: Is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf. 2010;19:977\u201382. https:\/\/doi.org\/10.1002\/pds.2009.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1293_CR29","unstructured":"Din L, Preuss CV. Prochlorperazine. StatPearls [Internet], Treasure Island (FL): StatPearls Publishing; 2025. Last updated 14 Aug 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537083\/. Accessed 19 Aug 2025."},{"key":"1293_CR30","first-page":"409","volume":"37","author":"C-H Kuo","year":"2008","unstructured":"Kuo C-H, Pang L, Chang R. Vertigo\u2014part 2\u2014management in general practice. Aust Fam Physician. 2008;37:409\u201313.","journal-title":"Aust Fam Physician"},{"key":"1293_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","volume":"32","author":"EC-C Lai","year":"2017","unstructured":"Lai EC-C, Pratt N, Hsieh C-Y, Lin S-J, Potteg\u00e5rd A, Roughead EE, et al. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies. Eur J Epidemiol. 2017;32:567\u201382. https:\/\/doi.org\/10.1007\/s10654-017-0281-8.","journal-title":"Eur J Epidemiol"},{"key":"1293_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/joim.12186","volume":"275","author":"J Hallas","year":"2014","unstructured":"Hallas J, Potteg\u00e5rd A. Use of self-controlled designs in pharmacoepidemiology. J Intern Med. 2014;275:581\u20139. https:\/\/doi.org\/10.1111\/joim.12186.","journal-title":"J Intern Med"},{"key":"1293_CR33","doi-asserted-by":"publisher","DOI":"10.12688\/hrbopenres.13622.1","volume":"5","author":"M Mattsson","year":"2022","unstructured":"Mattsson M, Flood M, Wallace E, Boland F, Moriarty F. Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2016\u20132021: a methodological report. HRB Open Res. 2022;5:67. https:\/\/doi.org\/10.12688\/hrbopenres.13622.1.","journal-title":"HRB Open Res"},{"key":"1293_CR34","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1016\/j.sapharm.2021.08.003","volume":"18","author":"EJ Morris","year":"2022","unstructured":"Morris EJ, Hollmann J, Hofer A-K, Bhagwandass H, Oueini R, Adkins LE, et al. Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: a scoping review. Res Soc Adm Pharm. 2022;18:3079\u201393. https:\/\/doi.org\/10.1016\/j.sapharm.2021.08.003.","journal-title":"Res Soc Adm Pharm"},{"key":"1293_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.1736","volume":"18","author":"I Tsiropoulos","year":"2009","unstructured":"Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf. 2009;18:483\u201391. https:\/\/doi.org\/10.1002\/pds.1736.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1293_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5723","volume":"33","author":"MT Rahbek","year":"2024","unstructured":"Rahbek MT, Hallas J, Lund LC. Trend adjustment of the sequence difference when performing sequence symmetry analyses. Pharmacoepidemiol Drug Saf. 2024;33:e5723. https:\/\/doi.org\/10.1002\/pds.5723.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1293_CR37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jamda.2021.06.035","volume":"23","author":"Y Chen","year":"2022","unstructured":"Chen Y, Huang S-T, Hsu T-C, Peng L-N, Hsiao F-Y, Chen L-K. Detecting suspected prescribing cascades by prescription sequence symmetry analysis of nationwide real-world data. J Am Med Dir Assoc. 2022;23:468-474.e6. https:\/\/doi.org\/10.1016\/j.jamda.2021.06.035.","journal-title":"J Am Med Dir Assoc"},{"key":"1293_CR38","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/pds.5293","volume":"30","author":"SM Vouri","year":"2021","unstructured":"Vouri SM, Jiang X, Morris EJ, Brumback BA, Winterstein AG. Use of negative controls in a prescription sequence symmetry analysis to reduce time-varying bias. Pharmacoepidemiol Drug Saf. 2021;30:1192\u20139. https:\/\/doi.org\/10.1002\/pds.5293.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1293_CR39","unstructured":"Lars Christian Lund. Sequence symmetry analysis in R. GitLab. GitLab 2024. https:\/\/gitlab.sdu.dk\/lclund\/sequence-symmetry-analysi. Accessed 9 May 2025."},{"key":"1293_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/02813432.2016.1207141","volume":"34","author":"JT J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen JT, Andersen JS, Tj\u00f8nneland A, Andersen ZJ. Determinants related to gender differences in general practice utilization: Danish Diet, Cancer and Health Cohort. Scand J Prim Health Care. 2016;34:240\u20139. https:\/\/doi.org\/10.1080\/02813432.2016.1207141.","journal-title":"Scand J Prim Health Care"},{"key":"1293_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/ageing\/afw074","volume":"45","author":"SG Morgan","year":"2016","unstructured":"Morgan SG, Weymann D, Pratt B, Smolina K, Gladstone EJ, Raymond C, et al. Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults. Age Ageing. 2016;45:535\u201342. https:\/\/doi.org\/10.1093\/ageing\/afw074.","journal-title":"Age Ageing"},{"key":"1293_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250567","volume":"16","author":"CJ Maxwell","year":"2021","unstructured":"Maxwell CJ, Mondor L, Kon\u00e9 AJP, Hogan DB, Wodchis WP. Sex differences in multimorbidity and polypharmacy trends: a repeated cross-sectional study of older adults in Ontario, Canada. PLoS ONE. 2021;16:e0250567. https:\/\/doi.org\/10.1371\/journal.pone.0250567.","journal-title":"PLoS ONE"},{"key":"1293_CR43","first-page":"893","volume":"112","author":"T Tatum","year":"2019","unstructured":"Tatum T, Curry P, Dunne B, Walsh K, Bennett K. Polypharmacy rates among patients over 45 years. Ir Med J. 2019;112:893.","journal-title":"Ir Med J"},{"key":"1293_CR44","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-7568(21)00054-4","volume":"2","author":"PA Rochon","year":"2021","unstructured":"Rochon PA, Petrovic M, Cherubini A, Onder G, O\u2019Mahony D, Sternberg SA, et al. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. Lancet Healthy Longev. 2021;2:e290-300. https:\/\/doi.org\/10.1016\/S2666-7568(21)00054-4.","journal-title":"Lancet Healthy Longev"},{"key":"1293_CR45","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.3399\/BJGP.2022.0181","volume":"73","author":"AS Doherty","year":"2023","unstructured":"Doherty AS, Boland F, Moriarty F, Fahey T, Wallace E. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study. Br J Gen Pract. 2023;73:e211\u20139. https:\/\/doi.org\/10.3399\/BJGP.2022.0181.","journal-title":"Br J Gen Pract"},{"key":"1293_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1096366","author":"Y Shan","year":"2023","unstructured":"Shan Y, Cheung L, Zhou Y, Huang Y, Huang RS. A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1096366.","journal-title":"Front Pharmacol"},{"key":"1293_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48:143\u201357. https:\/\/doi.org\/10.2165\/00003088-200948030-00001.","journal-title":"Clin Pharmacokinet"},{"key":"1293_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/a:1015239020403","volume":"11","author":"JI Westbrook","year":"2002","unstructured":"Westbrook JI, Talley NJ, Westbrook MT. Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res. 2002;11:283\u201391. https:\/\/doi.org\/10.1023\/a:1015239020403.","journal-title":"Qual Life Res"},{"key":"1293_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/s0002-9149(99)00322-7","volume":"84","author":"KA Milner","year":"1999","unstructured":"Milner KA, Funk M, Richards S, Wilmes RM, Vaccarino V, Krumholz HM. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol. 1999;84:396\u20139. https:\/\/doi.org\/10.1016\/s0002-9149(99)00322-7.","journal-title":"Am J Cardiol"},{"key":"1293_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10072-020-04643-8","volume":"41","author":"G Allais","year":"2020","unstructured":"Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurol Sci. 2020;41:429\u201336. https:\/\/doi.org\/10.1007\/s10072-020-04643-8.","journal-title":"Neurol Sci"},{"key":"1293_CR51","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/jgs.19282","volume":"73","author":"PA Rochon","year":"2025","unstructured":"Rochon PA, Li J, O\u2019Mahony D, Onder G, Petrovic M, Sternberg SA, et al. The impact of age, sex, and gender on polypharmacy and potential prescribing cascades: lessons from five databases. J Am Geriatr Soc. 2025;73:520\u201332. https:\/\/doi.org\/10.1111\/jgs.19282.","journal-title":"J Am Geriatr Soc"},{"key":"1293_CR52","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44097","author":"M Abubakar","year":"2023","unstructured":"Abubakar M, Prasad R, Salim SS, Basavaraju D, Khan M, Lateef IK, et al. Orthostatic hypotension in benign prostatic hyperplasia patients and its association with alpha-1 antagonist use: a comprehensive literature review. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.44097.","journal-title":"Cureus"},{"key":"1293_CR53","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension: developed by the Task Force on the Management of Elevated Blood Pressure and Hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024;45:3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J"},{"key":"1293_CR54","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11845-016-1407-9","volume":"186","author":"B O\u2019Dea","year":"2017","unstructured":"O\u2019Dea B, O\u2019Connor P, Lydon S, Murphy AW. Prevalence of burnout among Irish general practitioners: a cross-sectional study. Ir J Med Sci. 2017;186:447\u201353. https:\/\/doi.org\/10.1007\/s11845-016-1407-9.","journal-title":"Ir J Med Sci"},{"key":"1293_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m261","volume":"368","author":"KL Piggott","year":"2020","unstructured":"Piggott KL, Mehta N, Wong CL, Rochon PA. Using a clinical process map to identify prescribing cascades in your patient. BMJ. 2020;368:m261. https:\/\/doi.org\/10.1136\/bmj.m261.","journal-title":"BMJ"},{"key":"1293_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272418","volume":"17","author":"B Farrell","year":"2022","unstructured":"Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM. \u2018Kind of blurry\u2019: deciphering clues to prevent, investigate and manage prescribing cascades. PLoS ONE. 2022;17:e0272418. https:\/\/doi.org\/10.1371\/journal.pone.0272418.","journal-title":"PLoS ONE"},{"key":"1293_CR57","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","volume":"22","author":"M Delara","year":"2022","unstructured":"Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22:601. https:\/\/doi.org\/10.1186\/s12877-022-03279-x.","journal-title":"BMC Geriatr"},{"key":"1293_CR58","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/bcp.12600","volume":"80","author":"EA Saedder","year":"2015","unstructured":"Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015;80:808\u201317. https:\/\/doi.org\/10.1111\/bcp.12600.","journal-title":"Br J Clin Pharmacol"},{"key":"1293_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae116","volume":"53","author":"AA Jennings","year":"2024","unstructured":"Jennings AA, Doherty AS, Clyne B, Boland F, Moriarty F, Fahey T, et al. Stakeholder perceptions of and attitudes towards problematic polypharmacy and prescribing cascades: a qualitative study. Age Ageing. 2024;53:afae116. https:\/\/doi.org\/10.1093\/ageing\/afae116.","journal-title":"Age Ageing"},{"key":"1293_CR60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/pds.5362","volume":"31","author":"SM Vouri","year":"2022","unstructured":"Vouri SM, Morris EJ, Usmani SA, Reise R, Jiang X, Pepine CJ, et al. Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: loop diuretic prescribing cascade. Pharmacoepidemiol Drug Saf. 2022;31:72\u201381. https:\/\/doi.org\/10.1002\/pds.5362.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01293-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:49:48Z","timestamp":1774964988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01293-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01293-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. Ethical approval for the study was obtained from the Clinical Research Ethics Committee of University College Cork (ECM 4 (u) 20\/06\/2023 and ECM 3 (dd) 22\/10\/2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The datasets generated and analysed during the current study are available from the Health Service Executive Primary Care Reimbursement Service (HSE-PCRS).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The R scripts used to conduct the analyses in this study were applied to anonymised patient-level data generated by the data controller and include pre-processing steps specific to the supplied extract. As the underlying dataset cannot be shared and the pre-processing cannot be replicated externally, the scripts cannot be shared publicly in a meaningful way. Analytical code is available from the corresponding author upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All authors contributed to the study conception and design. Data cleaning and analysis were performed by Steven Gilmore and Dr Ann Sin\u00e9ad Doherty. The first draft of the manuscript was written by Steven Gilmore, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}